XcelCyte A/S: Financial statements 2024
CVR: 41466162
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
XcelCyte A/S (CVR 41466162) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -16,526 and a net result of DKK -19,254 compared with DKK -36,278 the year before. Equity in the 2024 report amounted to DKK -18,918. The company had 1 employee in the financial year.
- Gross Profit
- DKK -16,526
- Profit/Loss
- DKK -19,254
- Equity
- DKK -18,918
- Total Assets
- DKK 188,503
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -17 t. | -19 t. | -19 t. | 1 |
| 2023 | - | -21 t. | -36 t. | 336 | 1 |
| 2022 | - | -78 t. | -157 t. | 37 t. | 0 |
| 2021 | - | -2.2 mio. | -2.1 mio. | 194 t. | 1 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
XcelCyte A/S has published its annual report for 2023. Gross profit came to DKK -20,700, and the net result was DKK -36,278.
About XcelCyte A/S
XcelCyte A/S was a Danish company of the type Aktieselskab based in Aarhus C, founded in 2020. The company has been dissolved on 17 July 2026. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 1 employee (2021). In 2024, the company reported a gross profit of DKK -16,526 and a net result of DKK -19,254 compared with DKK -36,278 the year before. Equity in the 2024 report amounted to DKK -18,918.